DKSH has signed an agreement to acquire Taqkey Science (“Taqkey”) and Quantum Biotech (“Quantum”) in Taiwan. With these transactions, DKSH Technology further extends its scientific solutions and consumables businesses in line with the Business Units’ strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.
DKSH has received Global ISO certifications for environmental practices (ISO 14001) as well as occupational health and safety (ISO 45001) across multiple markets. This achievement reinforces DKSH’s commitment to sustainability and safety in its supply chains, which are continuously improved. DKSH aims to extend these ISO certifications to other key markets in the future.
Net sales reached CHF 11.1 billion (4.0% at CER1) Core EBIT increased to CHF 343.1 (8.4% at CER1) Core EBIT margin expanded by >10 basis points to 3.1% (4th consecutive year) Free Cash Flow of CHF 256.5 million (cash conversion of 113.6%) Dividend proposal of CHF 2.35 per share (+4.4%)2 Mid-term roadmap confirmed